Fri 27 Nov 2009 | 5:44 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. (HALO.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View HALO on other exchanges
As of  25 Nov 2009
5.98USD
Price Change
-0.14
Percent Change
-2.29%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Frost, Gregory 37 -- Vice President, Chief Scientific Officer, Director
Leff, Jonathan -- 2009 Vice President, Chief Medical Officer
Little, Robert 59 2006 Vice President, Chief Commercial Officer
Fallon, William 52 2006 Vice President - Manufacturing & Operations
Shepard, H. Michael -- 2009 Vice President - Discovery Research
Ramsay, David 44 2009 Vice President - Corporate Development
Lim, Jonathan 37 2003 President, Chief Executive Officer, Director
Patton, John 62 2000 Director
Engler, Robert 64 2004 Director
Matsui, Connie 55 2006 Director
Kirk, Randal 55 2007 Director
Falberg, Kathryn 48 2007 Director
Gustafson, Kurt -- 2009 Chief Financial Officer, Vice President - Finance
Kelley, Kenneth 50 2005 Chairman of the Board